Case number IPR2020-01053
Slayback Pharma LLC et al. v. Sumitomo Dainippon Pharma Co., Ltd. et al. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Feb 17, 2022 | 33 | board | Order: Order Denying POP Request Download |
| Jan 20, 2022 | 32 | board | Final Written Decision: original Download |
| Jan 7, 2022 | 3002 | board | E-Mail Requesting POP Review Download |
| Jan 7, 2022 | 31 | board | Notice: notice of receipt of POP request Download |
| Jan 6, 2022 | 30 | patent_own | Patent Owner's Request for Rehearing Download |
| Dec 7, 2021 | 3001 | board | Exhibit 3001 Download |
| Nov 12, 2021 | 28 | board | Other: Hearing transcript Download |
| Aug 9, 2021 | 1057 | petitioner | Petitioner's Demonstrative Exhibits Download |
| Aug 9, 2021 | 2143 | patent_own | Patent Owner's Demonstratives Download |
| Aug 9, 2021 | 27 | patent_own | Patent Owner's Updated Exhibit List Download |
| Jul 21, 2021 | 26 | board | ORDER Setting Oral Argument Download |
| Jul 8, 2021 | 25 | patent_own | Patent Owner's Sur-Reply Download |
| Jul 1, 2021 | 23 | petitioner | Petitioner's Request for Oral Argument Download |
| Jul 1, 2021 | 24 | patent_own | Patent Owner's Request for Oral Argument Download |
| Jun 24, 2021 | 1054 | petitioner | Public Version Stahl Deposition Transcript Download |
| Jun 24, 2021 | 1055 | petitioner | Public Version Reisetter Deposition Transcript Download |
| Jun 24, 2021 | 21 | petitioner | Public Version Petitioner's Reply Download |
| Jun 24, 2021 | 22 | petitioner | Certificate of Service Download |
| Jun 10, 2021 | 1051 | petitioner | Supplemental Declaration Dr. Kosten, M.D. Download |
| Jun 10, 2021 | 1052 | petitioner | Claim Construction Brief in District Court Download |
| Jun 10, 2021 | 1053 | petitioner | Claim Construction Brief at Federal Circuit Download |
| Jun 10, 2021 | 1056 | petitioner | Morrison Download |
| Jun 10, 2021 | 19 | petitioner | Petitioner's Motion to Seal Download |
| Apr 22, 2021 | 18 | petitioner | Notice of Depositions Drs. Reisetter and Stahl Download |
| Apr 19, 2021 | 17 | patent_own | Patent Owner's Updated Mandatory Notices Download |
| Mar 18, 2021 | 16 | petitioner | Petitioner's Objections to Exhibits to Patent Owner's Response Download |
| Mar 11, 2021 | 13 | patent_own | Patent Owner's Motion to Seal Download |
| Mar 11, 2021 | 14 | patent_own | Patent Owner's Response Download |
| Mar 11, 2021 | 2043 | patent_own | FDA Atypical Antipsychotic Drugs Information Download |
| Mar 11, 2021 | 2044 | patent_own | Franklin, Lurasidone for the treatment of bipolar depression an evidence-based review Download |
| Mar 11, 2021 | 2045 | patent_own | Shayegan et al., Atypical Antipsychotics Matching Receptor Profile to Individual Patient's Clinical Profile Download |
| Mar 11, 2021 | 2046 | patent_own | Kane et al. Clozapine for the Treatment-Resistant Schizophrenia Download |
| Mar 11, 2021 | 2047 | patent_own | Nashed et al., Olanzapine-Induced Weight Gain in Patients with Bipolar I Disorder A Meta-Analysis Download |
| Mar 11, 2021 | 2048 | patent_own | Download |
| Mar 11, 2021 | 2049 | patent_own | Seroquel Label Download |
| Mar 11, 2021 | 2050 | patent_own | Lieberman et al., Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia Download |
| Mar 11, 2021 | 2051 | patent_own | Thase, Quetiapine monotherapy for bipolar depression Download |
| Mar 11, 2021 | 2052 | patent_own | Hoyberg et al., Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations Download |
| Mar 11, 2021 | 2053 | patent_own | Lombardo et al., Two 6-Week, randomized, Double-Blind, Placebo- Controlled Studies of Ziprasidone in Outpatients with Bipolar I Depression Download |
| Mar 11, 2021 | 2054 | patent_own | Sachs et al., Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder Download |
| Mar 11, 2021 | 2055 | patent_own | Pacher et al., Cardiovascular Side Effects of New Antidepressants and Antipsychotics Download |
| Mar 11, 2021 | 2056 | patent_own | Stimmel at al., Ziprasidone An Atypical Antipsychotic Drug for the Treatment of Schizophrenia Download |
| Mar 11, 2021 | 2057 | patent_own | Fala, Latuda (Lurasidone HCL) Receives 2 New Indications for Use in Bipolar Depression as Monotherapy and as Adjunctive Therapy with Lithium or Valproate Download |
| Mar 11, 2021 | 2061 | patent_own | Meltzer et al., Lurasidone in the Treatment of Schizophrenia A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study Download |
| Mar 11, 2021 | 2064 | patent_own | Correll et al., Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia Download |
| Mar 11, 2021 | 2066 | patent_own | Reiffen et al., Generic Drug Industry Dynamics Download |
| Mar 11, 2021 | 2067 | patent_own | DiMasi et al. The price of innovation new estimates of drug development costs Download |
| Mar 11, 2021 | 2068 | patent_own | Samalin et al., Clinical potential of lurasidone in the management of schizophrenia Download |
| Mar 11, 2021 | 2070 | patent_own | Latuda Product Monograph Download |
| Mar 11, 2021 | 2071 | patent_own | Download |
| Mar 11, 2021 | 2072 | patent_own | Dainippon Sumitomo Pharma Co., Ltd., Supplementary Financial Data for Year Ended March 31, 2014 Download |
| Mar 11, 2021 | 2073 | patent_own | Jancin, Newer Atypical Antipsychotics Draw Praise Download |
| Mar 11, 2021 | 2077 | patent_own | Albright, Three key antipsychotics lose patent protection Download |
| Mar 11, 2021 | 2079 | patent_own | Pareek, Factors Affecting Non-Compliance to Psychotropic Drugs of Patients with Psychosis as Perceived by their Family Members Attending the Psychiatric Outpatient Department at Selected Hospital, Mangalore Download |
| Mar 11, 2021 | 2084 | patent_own | Ng-Mak et al., Patient Preferences for Important Attributes of Bipolar Depression Treatments Download |
| Mar 11, 2021 | 2085 | patent_own | Ng-Mak et al., Efficacy and Metabolic Effects of Lurasidone Versus Brexpiprazole in Schizophrenia Download |
| Mar 11, 2021 | 2086 | patent_own | Rajagopalan et al., Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia Download |
| Mar 11, 2021 | 2087 | patent_own | Mattingly et al., Switching to Lurasidone Following 12 Months of Treatment with Risperidone Download |
| Mar 11, 2021 | 2088 | patent_own | Mak et al., Cost Savings Associated with Improved Adherence Among Patients with Schizophrenia Using Lurasidone Download |
| Mar 11, 2021 | 2091 | patent_own | Comparison of Atypical Antipsychotics Download |
| Mar 11, 2021 | 2096 | patent_own | Poyurovsky et al., Attentuation of Olanzapine-Induced Weight Gain in Patients with Schizophrenia Download |
| Mar 11, 2021 | 2097 | patent_own | Poyurovsky et al., Attentuating Effect of Reboxetine on Appetite and Weight Gain in Olanzapine-Treated Schizophrenia Patients Download |
| Mar 11, 2021 | 2098 | patent_own | Zhuo et al., Topiramate and Metformin Are Effective Add-On Treatments in Controlling Anti-Psychotic Weight Gain Download |
| Mar 11, 2021 | 2131 | patent_own | Declaration of Dr. Stephen Stahl Download |
| Mar 11, 2021 | 2133 | patent_own | Declaration of Scott Stancell-Condron Download |
| Mar 11, 2021 | 2134 | patent_own | Deposition Transcript of Dr. Thomas Kosten Download |
| Mar 11, 2021 | 2135 | patent_own | Hummel et al., Clozapine as Add-On Medication in the Maintenance Treatment of Bipolar and Schizoaffective Disorder Download |
| Mar 11, 2021 | 2136 | patent_own | McElroy et al., Pharmacologic Agents for the Treatment of Acute Bipolar Mania Download |
| Mar 11, 2021 | 2137 | patent_own | Weiden, Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients with Schizophrenia, Psychiatric Services Download |
| Mar 11, 2021 | 2139 | patent_own | Tohen et al., Am J. Psychiatry Download |
| Mar 11, 2021 | 2140 | patent_own | Download |
| Mar 11, 2021 | 2141 | patent_own | News Release: FDA Approves Once-Daily Latuda (lurasidone HCl) for Treatment of Patients with Schizophrenia Download |
| Mar 11, 2021 | 2142 | patent_own | News Release Sunovion Pharmaceuticals Inc. Announces FDA Approval of Latuda (lurasidone HCl) as Monotherapy and Adjunctive Therapy in Adult Patients with Bipolar Depression Download |
| Mar 2, 2021 | 12 | board | Download |
| Jan 29, 2021 | 11 | patent_own | Patent Owner's Notice of Deposition of Thomas R. Kosten, M.D. Download |
| Dec 23, 2020 | 10 | petitioner | Objections to Evidence Filed with Preliminary Response Download |
| Dec 14, 2020 | 9 | patent_own | Joint Stipulation to Modify Due Dates 1, 2 and 3 Download |
| Dec 9, 2020 | 7 | board | Granting Institution of Inter Partes Review Download |
| Dec 9, 2020 | 8 | board | SCHEDULING ORDER Download |
| Sep 18, 2020 | 2001 | patent_own | History of the discovery and clinical introduction of chlorpromazine Download |
| Sep 18, 2020 | 2002 | patent_own | ZYPREXA (olanzapine) Label (2000) Download |
| Sep 18, 2020 | 2003 | patent_own | ABILIFY (aripiprazole) Label (2002) Download |
| Sep 18, 2020 | 2004 | patent_own | LATUDA (lurasidone) Label (2018) Download |
| Sep 18, 2020 | 2005 | patent_own | Excess Early Mortality in Schizophrenia Download |
| Sep 18, 2020 | 2006 | patent_own | Premature Mortality Among Adults with Schizophrenia in the United States Download |
| Sep 18, 2020 | 2007 | patent_own | Complaint filed 2/13/2018 Download |
| Sep 18, 2020 | 2008 | patent_own | Complaint filed 2/23/2018 Download |
| Sep 18, 2020 | 2009 | patent_own | Complaint filed 8/31/2018 Download |
| Sep 18, 2020 | 2010 | patent_own | Complaint filed 9/12/2018 Download |
| Sep 18, 2020 | 2011 | patent_own | Complaint filed 10/09/2018 Download |
| Sep 18, 2020 | 2012 | patent_own | Sumitomo Dainippon Pharma Announces Resolution of Disputes Under Consolidated Patent Infringement Lawsuit Regarding ANDAs for Latuda in the U.S. Download |
| Sep 18, 2020 | 2013 | patent_own | Treatment of Schizophrenia and Spectrum Disorders Download |
| Sep 18, 2020 | 2014 | patent_own | Novel antipsychotics Download |
| Sep 18, 2020 | 2015 | patent_own | Iloperidone, Asenapine and Lurasidone Download |
| Sep 18, 2020 | 2016 | patent_own | Diagnostic and Statistical Manual of Mental Disorders - Part 2 of 2 Download |
| Sep 18, 2020 | 2016 | patent_own | Diagnostic and Statistical Manual of Mental Disorders - Part 1 of 2 Download |
| Sep 18, 2020 | 2017 | patent_own | A Short History of Bipolar Disorder Download |
| Sep 18, 2020 | 2019 | patent_own | Diagnostic and Statistical Manual of Mental Disorders Download |
| Sep 18, 2020 | 2020 | patent_own | Second-Generation (Atypical) Antipsychotics and Metabolic Effects Download |
| Sep 18, 2020 | 2021 | patent_own | Antipsychotic-Induced Weight Gain Download |
| Sep 18, 2020 | 2022 | patent_own | Weight Gain from Novel Antipsychotic Drugs Download |
| Sep 18, 2020 | 2023 | patent_own | Risperdal Label Download |
| Sep 18, 2020 | 2024 | patent_own | Attachment 1 Ziprasidone Download |
| Sep 18, 2020 | 2025 | patent_own | Geodon Label - Part 1 of 2 Download |
| Sep 18, 2020 | 2025 | patent_own | Geodon Label - Part 2 of 2 Download |
| Sep 18, 2020 | 2026 | patent_own | Antipsychotics Download |
| Sep 18, 2020 | 2027 | patent_own | Stahl's Essential Psychopharmacology Download |
| Sep 18, 2020 | 2028 | patent_own | The Pharmacology of Weight Gain with Antipsychotics Download |
| Sep 18, 2020 | 2029 | patent_own | Weight Gain, Antipsychotic Drug Treatment and Pharmacogenomics Download |
| Sep 18, 2020 | 2030 | patent_own | Lurasidone Download |
| Sep 18, 2020 | 2031 | patent_own | Notice of allowance mailed 8/13/15 Download |
| Sep 18, 2020 | 2032 | patent_own | U.S. Patent No. 6,964,962 Download |
| Sep 18, 2020 | 2033 | patent_own | U.S. Patent Pub. No. 2001/0047010 Download |
| Sep 18, 2020 | 2034 | patent_own | Seroquel XR Download |
| Sep 18, 2020 | 2035 | patent_own | Novel Antipsychotics Download |
| Sep 18, 2020 | 2036 | patent_own | Weight Change and Antipsychotic Treatment in Patients with Schizophrenia Download |
| Sep 18, 2020 | 2037 | patent_own | Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia Download |
| Sep 18, 2020 | 2038 | patent_own | Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder Download |
| Sep 18, 2020 | 2039 | patent_own | The 5-HT2C receptor and antipsychotic induced weight gain Download |
| Sep 18, 2020 | 2040 | patent_own | Certified Translation of Horisawa et al. Download |
| Sep 18, 2020 | 2041 | patent_own | Schizophrenia Symptoms, Patterns and Statistics and Patterns Download |
| Sep 18, 2020 | 2042 | patent_own | Mental Health Download |
| Sep 18, 2020 | 6 | patent_own | Patent Owner's Preliminary Response Download |
| Jun 18, 2020 | 3 | board | Notice of Accord Filing Date Download |
| Jun 18, 2020 | 4 | patent_own | Patent Owner's Power of Attorney Download |
| Jun 18, 2020 | 5 | patent_own | Patent Owner's Mandatory Notices Download |
| Jun 5, 2020 | 1 | Power of Attorney Download | |
| Jun 5, 2020 | 1001 | EX-1001, U.S. Patent No. 9,815,827 Download | |
| Jun 5, 2020 | 1002 | EX-1002, Declaration of Dr. Thomas Kosten, M.D. Download | |
| Jun 5, 2020 | 1003 | EX-1003, The '827 Patent Application Download | |
| Jun 5, 2020 | 1004 | EX-1004, Priority Application Download | |
| Jun 5, 2020 | 1005 | EX-1005, Provisional Application Download | |
| Jun 5, 2020 | 1006 | EX-1006, Preliminary Amendment in the '827 Patent Application (October 5, 2015) ("Second Preliminary Amendment") Download | |
| Jun 5, 2020 | 1007 | EX-1007, Latuda(R) Information Download | |
| Jun 5, 2020 | 1008 | EX-1008, Loebel Download | |
| Jun 5, 2020 | 1009 | EX-1009, U.S. Patent No. 5,532,372 ("Saji Patent") Download | |
| Jun 5, 2020 | 1010 | EX-1010, Preliminary Amendment in Priority Application (Feb. 18, 2005) Download | |
| Jun 5, 2020 | 1011 | EX-1011 Download | |
| Jun 5, 2020 | 1012 | EX-1012 Download | |
| Jun 5, 2020 | 1013 | EX-1013 Download | |
| Jun 5, 2020 | 1014 | EX-1014 Download | |
| Jun 5, 2020 | 1015 | EX-1015, Declaration of Masaaki Ogasa in Priority Application (June17, 2008) Download | |
| Jun 5, 2020 | 1016 | EX-1016 Download | |
| Jun 5, 2020 | 1017 | EX-1017 Download | |
| Jun 5, 2020 | 1018 | EX-1018 Download | |
| Jun 5, 2020 | 1019 | EX-1019, U.S. Patent No. 9,174,975 Download | |
| Jun 5, 2020 | 1020 | EX-1020 Download | |
| Jun 5, 2020 | 1021 | EX-1021 Download | |
| Jun 5, 2020 | 1022 | EX-1022, DSM-IV Download | |
| Jun 5, 2020 | 1023 | EX-1023, DSM-IV TR Download | |
| Jun 5, 2020 | 1024 | EX-1024, DSM-5 Download | |
| Jun 5, 2020 | 1025 | EX-1025 Download | |
| Jun 5, 2020 | 1026 | EX-1026, Saji Amendment Download | |
| Jun 5, 2020 | 1027 | EX-1027, Saji March 1993 Amendment Download | |
| Jun 5, 2020 | 1028 | EX-1028, Horisawa, with translation from Japanese to English Download | |
| Jun 5, 2020 | 1029 | EX-1029 Download | |
| Jun 5, 2020 | 1030 | EX-1030, ICH-4 Download | |
| Jun 5, 2020 | 1031 | EX-1031, Federal Register Dose Optimization Guidelines 1994 Download | |
| Jun 5, 2020 | 1032 | EX-1032, European Patent No. 0,464,846, Saji EP '846 Download | |
| Jun 5, 2020 | 1033 | EX-1033 Download | |
| Jun 5, 2020 | 1034 | EX-1034 Download | |
| Jun 5, 2020 | 1035 | EX-1035, June 2013 Press Release Download | |
| Jun 5, 2020 | 1036 | EX-1036, Declaration of Sylvia D. Hall-Ellis, Ph.D. ("Librarian's Affidavit") Download | |
| Jun 5, 2020 | 1037 | EX-1037, Latuda Label 2012 Download | |
| Jun 5, 2020 | 1038 | EX-1038, Latuda Label July 2013 Download | |
| Jun 5, 2020 | 1039 | EX-1039, Olanzapine 2001 Download | |
| Jun 5, 2020 | 1040 | EX-1040, WO 01/76557 Download | |
| Jun 5, 2020 | 1041 | EX-1041, Allison Download | |
| Jun 5, 2020 | 1042 | EX-1042, Wetterling Download | |
| Jun 5, 2020 | 1044 | EX-1044, Caccia Download | |
| Jun 5, 2020 | 1046 | EX-1046, File History from PAIR for the '827 Patent Application Download | |
| Jun 5, 2020 | 1047 | EX-1047 Download | |
| Jun 5, 2020 | 1048 | EX-1048, Saji Application Download | |
| Jun 5, 2020 | 1049 | EX-1049 Download | |
| Jun 5, 2020 | 1050 | EX-1050, Petitioner's limitation by limitation Claim Listing for the '827 Patent Download | |
| Jun 5, 2020 | 2 | Petition for Inter Partes Review US 9815827 Download |
